Congenital heart disease is a diagnosis that covers an enormous range – from a small hole in the heart that will close on its own and never cause problems, to complex structural abnormalities requiring multiple open-heart surgeries in early life. The umbrella term captures something like forty distinct conditions, which vary enormously in severity, treatment, and long-term implications.
What they share is that they are structural differences present from birth, and that they affect a larger number of children than many people realise. When parents are told their baby has a heart defect – whether on the antenatal anomaly scan, at the newborn check, or after a child becomes ill – the initial response is almost always fear. Understanding the specific defect matters far more than the general category; and in the majority of cases, the trajectory is substantially better than that fear might suggest.
Healthbooq (healthbooq.com/apps/healthbooq-kids) covers complex health conditions in children and the families who support them.
The Scope of Congenital Heart Disease
Congenital heart disease (CHD) affects approximately 1 in 100 babies born in the UK – around 13 babies per day, or nearly 5,000 each year, according to the British Heart Foundation. The term describes any structural abnormality of the heart or great vessels present from birth. These range from minor lesions that resolve without intervention to severe, life-threatening conditions requiring urgent surgery.
The most common individual defects are ventricular septal defects (VSDs – holes between the lower chambers of the heart), which account for around 30% of all CHD. Many small VSDs close spontaneously in infancy. Atrial septal defects (ASDs – holes between the upper chambers), patent ductus arteriosus (PDA – failure of a fetal blood vessel to close after birth), pulmonary stenosis (narrowing of the pulmonary valve), coarctation of the aorta (narrowing of the main artery from the heart), aortic stenosis, and transposition of the great arteries are among the next most common.
Complex "cyanotic" conditions – where the defect reduces oxygenation of blood reaching the body – include tetralogy of Fallot (the most common cyanotic CHD, involving VSD, pulmonary stenosis, overriding aorta, and right ventricular hypertrophy), transposition of the great arteries, and hypoplastic left heart syndrome (HLHS), in which the left side of the heart is severely underdeveloped. HLHS was almost uniformly fatal before the 1980s; the Norwood procedure, developed by William Norwood, transformed survival, though the subsequent staged surgical approach (Norwood, Glenn, Fontan procedures) involves three operations in the first few years of life and significant long-term management.
Detection
Many significant congenital heart defects are detected at the 20-week anomaly ultrasound scan, which includes examination of the fetal heart. Complex conditions such as HLHS and transposition of the great arteries are often detectable here, allowing delivery planning at a specialist centre. Tetralogy of Fallot is detected prenatally in around 50-60% of cases.
The newborn examination at 6 hours of age and the pulse oximetry screening programme (which measures blood oxygen saturation and can detect cyanotic heart disease before symptoms develop) also contribute to early detection. Some defects are not identified until later – a murmur picked up at a routine check, or a child who presents with symptoms in infancy or childhood.
Treatment
Treatment depends entirely on the specific defect, its severity, and its haemodynamic consequences. Many minor defects require monitoring only, with surgical or interventional treatment only if the defect fails to close or causes symptoms. Significant defects almost always require some form of treatment.
Catheter-based interventions have replaced open-heart surgery for a growing number of defects: ASD closure with a device delivered via a catheter through a leg vein, PDA closure, and balloon valvuloplasty for pulmonary stenosis are examples. Open-heart surgery under cardiopulmonary bypass remains necessary for more complex repairs.
Paediatric cardiac surgery in the UK is concentrated at nine specialist centres (following the Safe and Sustainable review), which publish survival data. Outcomes overall have improved dramatically: thirty-day mortality after congenital heart surgery in the UK across all procedures is around 2-3%, though this varies considerably by procedure complexity. Most children with CHD survive to adulthood, and the number of adults living with CHD (ACHD) now exceeds the number of children with CHD – a transition that has required the development of specialist adult congenital heart disease services.
Neurodevelopmental Considerations
Children with significant CHD, particularly those who have had complex surgery requiring cardiopulmonary bypass in infancy, have higher rates of neurodevelopmental difficulties than the general population. These include learning difficulties, attention difficulties, processing speed and working memory problems, and social communication differences. Jane Newburger at Boston Children's Hospital and the Heart and Brain Group have documented these associations across multiple studies.
The neurodevelopmental effects are related to multiple factors: the underlying brain development in the context of altered fetal circulation, the effects of cardiac surgery (bypass time, temperature management, emboli), and the effects of prolonged hospitalisation and illness in early life. Developmental follow-up is increasingly incorporated into specialist CHD centres' pathways, with neurodevelopmental surveillance and referral for assessment where difficulties are identified.
Psychological Impact
Living with CHD – or supporting a child with CHD – has psychological dimensions that extend beyond the immediate medical management. Parental anxiety following a cardiac diagnosis is substantial and persistent; children with CHD have higher rates of anxiety, depression, and school difficulties than the general population. The cardiology community has increasingly recognised that the psychological needs of children with CHD and their families are part of the medical management of the condition, not a separate concern.
The Children's Heart Federation is the main umbrella organisation for children with heart conditions and their families in the UK, and many specialist centres have associated family support services.
Key Takeaways
Congenital heart disease (CHD) is the most common birth defect, affecting approximately 1 in 100 babies born in the UK. It encompasses a wide range of structural abnormalities of the heart, from minor defects that close spontaneously to complex conditions requiring multiple surgical procedures. Outcomes for children with CHD have improved dramatically over the past 50 years: most children born with CHD today, including those with the most complex conditions, survive to adulthood. The challenge has shifted from survival to understanding and supporting the long-term health, neurodevelopmental, and psychological needs of a growing population of adults who were born with CHD.
